Skip to main content
Equibles
SKIN logo

SKIN · SkinHealth Systems Inc. · Metrics

Track SKIN — free

Use SKIN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.70 -0.04 (-5.03%)
Rebalance outlook locked
Market Cap
$89.15M
Shares
130.14M

SKIN metrics

71 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.74
Market cap
$89.15M

Price action

20 metrics
Price change (1W)
+0.0%
Price change (30D)
+7.0%
Price change (3M)
+12.7%
Price change (6M)
-39.9%
Price change (YTD)
-50.7%
Price change (1Y)
-65.9%
Trailing year
Price change (5Y)
-97.5%
52-week high
$2.63
52-week low
$0.58
Change from 52-week high
-74.0%
Change from 52-week low
+18.1%
Annualized volatility
99.2%
Annualized volatility (3M)
120.0%
Beta
1.3
RSI (14D)
50.0
Price vs SMA 50
-6.3%
Price vs SMA 200
-31.5%
Avg volume (3M)
2.33M
Relative volume
0.1
Average dollar volume
$2.25M

Company

3 metrics
Sector
Consumer Defensive
Industry
Household & Personal Products
Shares outstanding
130.14M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.3×
reciprocal yield 325.4%
P / book
1.6
reciprocal yield 62.3%
FCF yield
23.7%
TTM · current market cap
Buyback yield
—
P / FCF
4.2
reciprocal yield 23.7%
P / operating cash flow
4.1
reciprocal yield 24.6%
Earnings yield
-31.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.0×
reciprocal yield 104.0%
EV / revenue historical average (5Y)
1.0×
reciprocal yield 104.0%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
66.4%
Operating margin
-1.5%
Trailing 12 months
Net margin
-9.8%
Gross profit (TTM)
$192.45M
Operating profit (TTM)
−$4.31M
Net income (TTM)
−$28.43M
Trailing 12 months
Diluted EPS (TTM)
$-0.18
FCF margin
7.3%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-0.86

Growth

11 metrics
Revenue growth YoY
-7.8%
Year over year
Net income growth YoY
-113.5%
Revenue (TTM)
$290.05M
Trailing 12 months
EPS growth YoY
-166.7%
Shares change YoY
-7.6%
Year over year · fewer shares
Revenue CAGR (3Y)
-6.3%
Revenue CAGR (5Y)
+20.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-51.2%
Return on assets
-5.8%
Debt / equity
—
Current ratio
1.8
EBITDA (TTM)
—
Free cash flow (TTM)
$21.14M
Quick ratio
1.5
Interest coverage
-0.2
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$206.07M
Total assets
$486.57M
Total debt
$363.39M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$21.96M
Capital expenditures (TTM)
$817,000
R&D (TTM)
$5.89M
SG&A (TTM)
—
Stock compensation (TTM)
$11.01M
R&D / revenue
2.0%
Stock compensation / revenue
3.8%

Ownership (13F)

3 metrics
13F filers
97
13F filer change QoQ
-20
Institutional ownership
54.3%

Short interest

3 metrics
Short interest
5.4%
Latest settlement · 16.8 days to cover
Days to cover
16.8d
Short-squeeze score
60 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1818093 CUSIP 88331L108 13F (30d) 67 filings 67 filers Visit website Investor relations